Olema Pharmaceuticals inc (OLMA)
11.74
-0.14
(-1.14%)
USD |
NASDAQ |
Jun 25, 16:00
11.74
0.00 (0.00%)
Pre-Market: 20:00
Olema Pharmaceuticals Cash and Short Term Investments (Quarterly): 248.98M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 248.98M |
| December 31, 2023 | 261.81M |
| September 30, 2023 | 276.90M |
| June 30, 2023 | 167.44M |
| March 31, 2023 | 185.95M |
| December 31, 2022 | 204.42M |
| September 30, 2022 | 222.60M |
| June 30, 2022 | 240.71M |
| Date | Value |
|---|---|
| March 31, 2022 | 267.87M |
| December 31, 2021 | 287.25M |
| September 30, 2021 | 305.95M |
| June 30, 2021 | 318.14M |
| March 31, 2021 | 326.97M |
| December 31, 2020 | 338.55M |
| September 30, 2020 | 127.82M |
| December 31, 2019 | 0.068M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
0.068M
Minimum
Dec 2019
338.55M
Maximum
Dec 2020
236.34M
Average
255.39M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Fate Therapeutics Inc | 383.54M |
| Vera Therapeutics Inc | 403.66M |
| Janux Therapeutics Inc | 651.76M |
| NovaBay Pharmaceuticals Inc | 1.823M |
| Palatin Technologies Inc | 10.01M |